This study was performed to demonstrate that RNA isolated from cell lines and cervical cytology specimens stored in SurePath preservative fluid would be functional in real-time RT-PCR assays. RNA was isolated from cervical cell lines or cytology samples stored in SurePath preservative at room temperature for 2-5 weeks using five commercially available RNA purification kits, three of which contain proteinases. The quality of the RNA was assessed by real time RT-PCR amplification of GAPDH, GUSB, U1A, HPV 16 and 18 E6 mRNAs. RNA was isolated successfully from cells that were stored in SurePath preservative fluid with only the three protocols that contained proteinases. GAPDH was amplified in 98-100% of the samples, GUSB in 90-98%, and the least abundant transcript, U1A, was amplified in 81-96% of the samples. HPV 16 and 18 E6 transcripts were detected in 56% of high grade, 39% of low grade and 2% of normal samples, with a concordance between DNA genotype and E6 mRNA expression of 97%. We demonstrated that RNA can be extracted from cervical cell lines and cytology specimens stored in BD SurePath preservative fluid with three different procedures that all contain proteinases. This RNA is suitable for real-time RT-PCR applications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jviromet.2008.11.011DOI Listing

Publication Analysis

Top Keywords

stored surepath
20
surepath preservative
20
cell lines
16
preservative fluid
16
cytology specimens
12
specimens stored
12
rna isolated
12
lines cervical
8
cervical cytology
8
real time
8

Similar Publications

Article Synopsis
  • Molecular targeted therapies are increasingly reliant on molecular testing from cytology specimens, prompting a study to find the best preservation methods for liquid-based cytology (LBC) samples.
  • The study involved 35 lung cancer specimens, which were preserved using different methods (SurePath™, Frozen, and LBC Cell Block) and evaluated over a 36-month period for the quality and quantity of DNA and RNA.
  • Results indicated that the LBC Cell Block method yielded higher concentrations and better quality of DNA and RNA compared to other methods, making it a promising option for long-term preservation for molecular testing.
View Article and Find Full Text PDF

Aim: The Papilloplex high-risk human papillomavirus (hrHPV) test (Genefirst, Oxford, UK) is a single tube real-time HPV test which provides multiplex detection and separate identification of 14 hrHPV types. Here, we present the clinical validation of the test in SurePath samples in comparison to a clinically validated reference test, the GP5+/6+Enzyme ImmunoAssay (GP5+/6+EIA) using the VALGENT (VALidation of HPV GENotyping Tests) framework.

Methods: Clinical performance was assessed using 998 unselected, cervical screening samples enriched with 297 cytologically abnormal specimens (100 atypical squamous cells of unspecified significance, 100 low-grade squamous intraepithelial lesions, 97 high-grade squamous intraepithelial lesions).

View Article and Find Full Text PDF

Introduction/objective: Liquid-based cytology (LBC) is advantageous as multiple stained specimens can be prepared and used for additional assays such as immunocytochemical and molecular-pathological investigations. Two types of preservative-fixative solutions (fixatives) are used for nongynecologic specimens used in the BD SurePath-LBC (SP-LBC) method, and their components vary. However, few studies have evaluated the differences in antigen-retaining ability between these fixatives.

View Article and Find Full Text PDF

The idation of HPV otyping ests (VALGENT) framework is an international cooperation designed to evaluate human papillomavirus (HPV) assays with genotyping capabilities. Here, we assessed the performance of the BD Onclarity assay using Danish SurePath cervical screening samples collected under the fourth VALGENT installment, consisting of 998 consecutive samples from a screening population and 297 enriched samples with abnormal cytology (100 with atypical squamous cells of undetermined significance [ASCUS], 100 with low-grade squamous intraepithelial lesions [LSIL], and 97 with high-grade squamous intraepithelial lesions [HSIL]). The Onclarity assay detects six HPV genotypes individually (genotypes 16, 18, 31, 45, 51, and 52) and eight genotypes in three bulks (genotypes 33 and 58; genotypes 56, 59, and 66; and genotypes 35, 39, and 68).

View Article and Find Full Text PDF

The effect of the small amount of formaldehyde in the SurePath liquid when establishing protocols for immunocytochemistry.

Cytojournal

November 2016

Department of Pathology, Akershus University Hospital, Lørenskog, Norway; Campus Ahus Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Background: SurePath is an ethanol-based liquid fixative. In addition to ethanol, it also contains a small amount of formaldehyde (<0.2%).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!